Archive for May, 2009
Wednesday, May 27th, 2009
Is the financial downturn affecting your practice? Does it seem like you’re seeing fewer patients? Though you can’t change the economy, there are things you can do to strengthen patient relationships and increase loyalty, referrals and revenue!
Make the most of your down time.
A lag in appointments can be a great ...
Posted in General | No Comments »
Friday, May 22nd, 2009
As of April 21, 2009, 48 pharmaceutical companies have agreed to abide by the PhRMA Code on Interactions with Healthcare Professionals. For a list of participating companies, click here.
The PhRMA Code aims to improve ethical behavior between salespeople and healthcare professionals by eliminating gifts and focusing interactions on products, providing ...
Posted in General, In the News | 1 Comment »
Thursday, May 21st, 2009
Before coming to Medical Arts Press, I managed a team of seven people in a high-paced environment. We were face to face with customers ten hours a day, and were dependent on each other to keep the branch running smoothly. And the days my team got along – those were ...
Posted in General, Practice Management, Staff Development | 6 Comments »
Tuesday, May 19th, 2009
Who isn’t looking to save a buck these days? We all are. And, if you haven’t integrated coupons into your marketing plan, now is the time to do it. In this economy, patients are likely to skip the extra services – like teeth whitening or doggie daycare – in an ...
Posted in General, Marketing Ideas; Patient Relations | 27 Comments »
Monday, May 18th, 2009
Staff meetings are important to any practice. It's your time to get the staff together to discuss new changes or important matters within the practice. But let’s face it – while these meetings are necessary, they can often be mind-numbing and unproductive. And, if there's no clear-cut agenda, they can ...
Posted in General, Practice Management | No Comments »
Friday, May 15th, 2009
The FDA has added a new warning label to the popular Genentech and OSI Pharmaceuticals cancer drug following reports of skin reactions, eye problems, gastrointestinal perforations and some fatalities. To read Genentech and OSI’s letter to healthcare professionals, click here:
http://www.fda.gov/medwatch/safety/2009/Tarceva_DHCP_Letter_April09.pdf
Posted in General, In the News | No Comments »
